Submitted by amarin on Mon, 07/08/2024 - 11:30 Home ID Reference 24166 Tags General Releases Page Tags Global News / Press Release News & Media News title Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR)
